グローバル動物用駆虫薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Veterinary Antiparasitic Drugs - Global Top Players Market Share and Ranking 2026

レポートID：
223838
発表時期：
2026-03-03
レポート形式：
PDF
産業カテゴリー：
薬品及びサプリメント
レポート言語：
英語、日本語
ページ数：
118
発行会社（調査会社）：
YHResearch

レポートの概要

本報告書は、世界の動物用駆虫薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から動物用駆虫薬市場を分析し、需要構造と成長特性を明確化します。
動物用駆虫薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、動物用駆虫薬に関する的確な意思決定を行うための実践的なインサイトを提供します。

 主要動物用駆虫薬市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは動物用駆虫薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
動物用駆虫薬市場の主要企業には以下が含まれます：
Weefsel Pharma
Meiji Group
Biowet
HPRA
Medinfar Sorologico
Boehringer Ingelheim Animal Health
VET -AGRO
Mobedco
Merck KGaA
VIC
Vetsintez
Cadila Pharmaceuticals
Watson International Limited
VivaldisGlenmark Pharmaceuticals Limited 

製品別
Antihelmintics
Antiprotozoal Drugs 

アプリケーション別
Farm
Zoo
Others 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
動物用駆虫薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
動物用駆虫薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に動物用駆虫薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に動物用駆虫薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、動物用駆虫薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、動物用駆虫薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
動物用駆虫薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 動物用駆虫薬市場の全体像と成長見通し
動物用駆虫薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が動物用駆虫薬市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
動物用駆虫薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
動物用駆虫薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から動物用駆虫薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
動物用駆虫薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
動物用駆虫薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします

Description

According to YH Research, the global market for Veterinary Antiparasitic Drugs should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Parasitic infections are very common in the livestock industry and have serious consequences for animal health and performance. Therefore, the use of antiparasitic drugs is an important means of preventing and treating parasitic infections.

This report studies and analyses global Veterinary Antiparasitic Drugs status and future trends, helps the client to determine the Veterinary Antiparasitic Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Antiparasitic Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Veterinary Antiparasitic Drugs market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Veterinary Antiparasitic Drugs sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Veterinary Antiparasitic Drugs sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Veterinary Antiparasitic Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Veterinary Antiparasitic Drugs key producing regions, capacity, production, and year over year growth
(6) Veterinary Antiparasitic Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Weefsel Pharma
    Meiji Group
    Biowet
    HPRA
    Medinfar Sorologico
    Boehringer Ingelheim Animal Health
    VET -AGRO
    Mobedco
    Merck KGaA
    VIC
    Vetsintez
    Cadila Pharmaceuticals
    Watson International Limited
    VivaldisGlenmark Pharmaceuticals Limited

Market segment by Type, covers
    Antihelmintics
    Antiprotozoal Drugs

Market segment by Application, can be divided into
    Farm
    Zoo
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Veterinary Antiparasitic Drugs product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Veterinary Antiparasitic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Veterinary Antiparasitic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Veterinary Antiparasitic Drugs, percent & CAGR, 2021-2032
Chapter 5: Veterinary Antiparasitic Drugs industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions

Table of Contents

1 Market Overview
    1.1 Veterinary Antiparasitic Drugs Definition
    1.2 Global Veterinary Antiparasitic Drugs Market Size and Forecast
        1.2.1 By Consumption Value, Global Veterinary Antiparasitic Drugs Market Size, 2021-2032
        1.2.2 By Sales Quantity, Global Veterinary Antiparasitic Drugs Market Size, 2021-2032
        1.2.3 Global Veterinary Antiparasitic Drugs Average Selling Price (ASP), 2021-2032
    1.3 Japan Veterinary Antiparasitic Drugs Market Size and Forecast
        1.3.1 By Consumption Value, Japan Veterinary Antiparasitic Drugs Market Size, 2021-2032
        1.3.2 By Sales Quantity, Japan Veterinary Antiparasitic Drugs Market Size, 2021-2032
        1.3.3 Japan Veterinary Antiparasitic Drugs Average Selling Price (ASP), 2021-2032
    1.4 Share of Japan Veterinary Antiparasitic Drugs Market with Respect to the Global Market
        1.4.1 By Consumption Value, Japan Veterinary Antiparasitic Drugs Market Share in Global, 2021-2032
        1.4.2 By Sales Quantity, Japan Veterinary Antiparasitic Drugs Market Share in Global, 2021-2032
        1.4.3 Veterinary Antiparasitic Drugs Market Size: Japan VS Global, 2021-2032
    1.5 Veterinary Antiparasitic Drugs Market Dynamics
        1.5.1 Veterinary Antiparasitic Drugs Market Drivers
        1.5.2 Veterinary Antiparasitic Drugs Market Restraints
        1.5.3 Veterinary Antiparasitic Drugs Industry Trends
        1.5.4 Veterinary Antiparasitic Drugs Industry Policy

2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Veterinary Antiparasitic Drugs, Global Market Share by Company, 2021-2026
    2.2 By Sales Quantity of Veterinary Antiparasitic Drugs, Global Market Share by Company, 2021-2026
    2.3 Veterinary Antiparasitic Drugs Average Selling Price (ASP) by Company, 2021-2026
    2.4 Global Veterinary Antiparasitic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Veterinary Antiparasitic Drugs Concentration Ratio
    2.6 Global Veterinary Antiparasitic Drugs Mergers & Acquisitions, Expansion Plans
    2.7 Global Veterinary Antiparasitic Drugs Manufacturers Product Type
    2.8 Head Office and Veterinary Antiparasitic Drugs Production Site of Key Manufacturer
    2.9 Veterinary Antiparasitic Drugs Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
    3.1 By Revenue of Veterinary Antiparasitic Drugs, Japan Market Share by Company, 2021-2026
    3.2 By Sales Quantity of Veterinary Antiparasitic Drugs, Japan Market Share by Company, 2021-2026
    3.3 Japan Veterinary Antiparasitic Drugs Veterinary Antiparasitic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
    4.1 Global Veterinary Antiparasitic Drugs Capacity, Output and Capacity Utilization, 2021-2032
    4.2 Global Veterinary Antiparasitic Drugs Capacity by Region
    4.3 Global Veterinary Antiparasitic Drugs Production & Forecast by Region, 2021 VS 2025 VS 2032
    4.4 Global Veterinary Antiparasitic Drugs Production by Region, 2021-2032
    4.5 Global Veterinary Antiparasitic Drugs Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
    5.1 Veterinary Antiparasitic Drugs Industry Chain
    5.2 Veterinary Antiparasitic Drugs Upstream Analysis
        5.2.1 Veterinary Antiparasitic Drugs Core Raw Materials
        5.2.2 Main Manufacturers of Veterinary Antiparasitic Drugs Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Veterinary Antiparasitic Drugs Production Mode
    5.6 Veterinary Antiparasitic Drugs Procurement Model
    5.7 Veterinary Antiparasitic Drugs Industry Sales Model and Sales Channels
        5.7.1 Veterinary Antiparasitic Drugs Sales Model
        5.7.2 Veterinary Antiparasitic Drugs Typical Distributors

6 Sights by Type
    6.1 Veterinary Antiparasitic Drugs Classification by Type
        6.1.1 Antihelmintics
        6.1.2 Antiprotozoal Drugs
    6.2 by Type, Global Veterinary Antiparasitic Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Type, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032
    6.4 by Type, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032
    6.5 by Type, Global Veterinary Antiparasitic Drugs Average Selling Price (ASP), 2021-2032

7 Sights by Application
    7.1 Veterinary Antiparasitic Drugs Segment by Application
        7.1.1 Farm
        7.1.2 Zoo
        7.1.3 Others
    7.2 by Application, Global Veterinary Antiparasitic Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    7.3 by Application, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032
    7.4 by Application, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032
    7.5 by Application, Global Veterinary Antiparasitic Drugs Price, 2021-2032

8 Sales Sights by Region
    8.1 By Region, Global Veterinary Antiparasitic Drugs Consumption Value, 2021 VS 2025 VS 2032
    8.2 By Region, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032
    8.3 By Region, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032
    8.4 North America
        8.4.1 North America Veterinary Antiparasitic Drugs Market Size & Forecasts, 2021-2032
        8.4.2 By Country, North America Veterinary Antiparasitic Drugs Market Size Market Share
    8.5 Europe
        8.5.1 Europe Veterinary Antiparasitic Drugs Market Size & Forecasts, 2021-2032
        8.5.2 By Country, Europe Veterinary Antiparasitic Drugs Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Veterinary Antiparasitic Drugs Market Size & Forecasts, 2021-2032
        8.6.2 By Country/Region, Asia Pacific Veterinary Antiparasitic Drugs Market Size Market Share
    8.7 South America
        8.7.1 South America Veterinary Antiparasitic Drugs Market Size & Forecasts, 2021-2032
        8.7.2 By Country, South America Veterinary Antiparasitic Drugs Market Size Market Share
    8.8 Middle East & Africa

9 Sales Sights by Country Level
    9.1 By Country, Global Veterinary Antiparasitic Drugs Market Size & CAGR, 2021 VS 2025 VS 2032
    9.2 By Country, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032
    9.3 By Country, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032
    9.4 United States
        9.4.1 United States Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.4.2 by Type, United States Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.4.3 by Application, United States Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.5 Europe
        9.5.1 Europe Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.5.2 by Type, Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.5.3 by Application, Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.6 China
        9.6.1 China Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.6.2 by Type, China Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.6.3 by Application, China Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.7 Japan
        9.7.1 Japan Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.7.2 by Type, Japan Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.7.3 by Application, Japan Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.8 South Korea
        9.8.1 South Korea Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.8.2 by Type, South Korea Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.8.3 by Application, South Korea Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.9 Southeast Asia
        9.9.1 Southeast Asia Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.9.2 by Type, Southeast Asia Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.9.3 by Application, Southeast Asia Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.10 India
        9.10.1 India Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.10.2 by Type, India Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.10.3 by Application, India Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Veterinary Antiparasitic Drugs Market Size, 2021-2032
        9.11.2 by Type, Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
        9.11.3 by Application, Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
    10.1 Weefsel Pharma
        10.1.1 Weefsel Pharma Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Weefsel Pharma Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.1.3 Weefsel Pharma Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.1.4 Weefsel Pharma Company Profile and Main Business
        10.1.5 Weefsel Pharma Recent Developments
    10.2 Meiji Group
        10.2.1 Meiji Group Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Meiji Group Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.2.3 Meiji Group Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.2.4 Meiji Group Company Profile and Main Business
        10.2.5 Meiji Group Recent Developments
    10.3 Biowet
        10.3.1 Biowet Company Information, Head Office, Market Area, and Industry Position
        10.3.2 Biowet Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.3.3 Biowet Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.3.4 Biowet Company Profile and Main Business
        10.3.5 Biowet Recent Developments
    10.4 HPRA
        10.4.1 HPRA Company Information, Head Office, Market Area, and Industry Position
        10.4.2 HPRA Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.4.3 HPRA Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.4.4 HPRA Company Profile and Main Business
        10.4.5 HPRA Recent Developments
    10.5 Medinfar Sorologico
        10.5.1 Medinfar Sorologico Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Medinfar Sorologico Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.5.3 Medinfar Sorologico Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.5.4 Medinfar Sorologico Company Profile and Main Business
        10.5.5 Medinfar Sorologico Recent Developments
    10.6 Boehringer Ingelheim Animal Health
        10.6.1 Boehringer Ingelheim Animal Health Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.6.3 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.6.4 Boehringer Ingelheim Animal Health Company Profile and Main Business
        10.6.5 Boehringer Ingelheim Animal Health Recent Developments
    10.7 VET -AGRO
        10.7.1 VET -AGRO Company Information, Head Office, Market Area, and Industry Position
        10.7.2 VET -AGRO Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.7.3 VET -AGRO Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.7.4 VET -AGRO Company Profile and Main Business
        10.7.5 VET -AGRO Recent Developments
    10.8 Mobedco
        10.8.1 Mobedco Company Information, Head Office, Market Area, and Industry Position
        10.8.2 Mobedco Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.8.3 Mobedco Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.8.4 Mobedco Company Profile and Main Business
        10.8.5 Mobedco Recent Developments
    10.9 Merck KGaA
        10.9.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
        10.9.2 Merck KGaA Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.9.3 Merck KGaA Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.9.4 Merck KGaA Company Profile and Main Business
        10.9.5 Merck KGaA Recent Developments
    10.10 VIC
        10.10.1 VIC Company Information, Head Office, Market Area, and Industry Position
        10.10.2 VIC Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.10.3 VIC Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.10.4 VIC Company Profile and Main Business
        10.10.5 VIC Recent Developments
    10.11 Vetsintez
        10.11.1 Vetsintez Company Information, Head Office, Market Area, and Industry Position
        10.11.2 Vetsintez Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.11.3 Vetsintez Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.11.4 Vetsintez Company Profile and Main Business
        10.11.5 Vetsintez Recent Developments
    10.12 Cadila Pharmaceuticals
        10.12.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        10.12.2 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.12.3 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.12.4 Cadila Pharmaceuticals Company Profile and Main Business
        10.12.5 Cadila Pharmaceuticals Recent Developments
    10.13 Watson International Limited
        10.13.1 Watson International Limited Company Information, Head Office, Market Area, and Industry Position
        10.13.2 Watson International Limited Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.13.3 Watson International Limited Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.13.4 Watson International Limited Company Profile and Main Business
        10.13.5 Watson International Limited Recent Developments
    10.14 VivaldisGlenmark Pharmaceuticals Limited
        10.14.1 VivaldisGlenmark Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
        10.14.2 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Models, Specifications, and Application
        10.14.3 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.14.4 VivaldisGlenmark Pharmaceuticals Limited Company Profile and Main Business
        10.14.5 VivaldisGlenmark Pharmaceuticals Limited Recent Developments

11 Conclusion

12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer

Table of Figures

List of Tables
Table 1. Veterinary Antiparasitic Drugs Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
Table 2. Veterinary Antiparasitic Drugs Market Restraints
Table 3. Veterinary Antiparasitic Drugs Market Trends
Table 4. Veterinary Antiparasitic Drugs Industry Policy
Table 5. Global Veterinary Antiparasitic Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 6. Global Veterinary Antiparasitic Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 7. Global Veterinary Antiparasitic Drugs Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 8. Global Veterinary Antiparasitic Drugs Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 9. Global Veterinary Antiparasitic Drugs Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit)
Table 10. Global Veterinary Antiparasitic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Veterinary Antiparasitic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Veterinary Antiparasitic Drugs Manufacturers Product Type
Table 13. Head Office and Veterinary Antiparasitic Drugs Production Site of Key Manufacturer
Table 14. Veterinary Antiparasitic Drugs Capacity of Major Manufacturers and Future Plan
Table 15. Japan Veterinary Antiparasitic Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 16. Japan Veterinary Antiparasitic Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 17. Japan Veterinary Antiparasitic Drugs Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 18. Japan Veterinary Antiparasitic Drugs Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 19. Global Veterinary Antiparasitic Drugs Production & Forecast by Region, 2021 VS 2025 VS 2032, (K Units)
Table 20. Global Veterinary Antiparasitic Drugs Production by Region, 2021-2026, (K Units)
Table 21. Global Veterinary Antiparasitic Drugs Production Forecast by Region, 2027-2032, (K Units)
Table 22. Global Key Players of Veterinary Antiparasitic Drugs Upstream (Raw Materials)
Table 23. Global Veterinary Antiparasitic Drugs Typical Customers
Table 24. Veterinary Antiparasitic Drugs Typical Distributors
Table 25. by Type, Global Veterinary Antiparasitic Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 26. by Application, Global Veterinary Antiparasitic Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 27. By Region, Global Veterinary Antiparasitic Drugs Consumption Value, 2021 VS 2025 VS 2032, US$ Million
Table 28. By Region, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032, US$ Million
Table 29. By Region, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Table 30. By Country, Global Veterinary Antiparasitic Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 31. By Country, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032, US$ Million
Table 32. By Country, Global Veterinary Antiparasitic Drugs Consumption Value Market Share, 2021-2032
Table 33. By Country, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Table 34. By Country, Global Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2021-2032
Table 35. Weefsel Pharma Company Information, Head Office, Market Area, and Industry Position
Table 36. Weefsel Pharma Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 37. Weefsel Pharma Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 38. Weefsel Pharma Company Profile and Main Business
Table 39. Weefsel Pharma Recent Developments
Table 40. Meiji Group Company Information, Head Office, Market Area, and Industry Position
Table 41. Meiji Group Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 42. Meiji Group Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 43. Meiji Group Company Profile and Main Business
Table 44. Meiji Group Recent Developments
Table 45. Biowet Company Information, Head Office, Market Area, and Industry Position
Table 46. Biowet Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 47. Biowet Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 48. Biowet Company Profile and Main Business
Table 49. Biowet Recent Developments
Table 50. HPRA Company Information, Head Office, Market Area, and Industry Position
Table 51. HPRA Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 52. HPRA Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 53. HPRA Company Profile and Main Business
Table 54. HPRA Recent Developments
Table 55. Medinfar Sorologico Company Information, Head Office, Market Area, and Industry Position
Table 56. Medinfar Sorologico Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 57. Medinfar Sorologico Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 58. Medinfar Sorologico Company Profile and Main Business
Table 59. Medinfar Sorologico Recent Developments
Table 60. Boehringer Ingelheim Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 61. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 62. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 63. Boehringer Ingelheim Animal Health Company Profile and Main Business
Table 64. Boehringer Ingelheim Animal Health Recent Developments
Table 65. VET -AGRO Company Information, Head Office, Market Area, and Industry Position
Table 66. VET -AGRO Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 67. VET -AGRO Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 68. VET -AGRO Company Profile and Main Business
Table 69. VET -AGRO Recent Developments
Table 70. Mobedco Company Information, Head Office, Market Area, and Industry Position
Table 71. Mobedco Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 72. Mobedco Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 73. Mobedco Company Profile and Main Business
Table 74. Mobedco Recent Developments
Table 75. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 76. Merck KGaA Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 77. Merck KGaA Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 78. Merck KGaA Company Profile and Main Business
Table 79. Merck KGaA Recent Developments
Table 80. VIC Company Information, Head Office, Market Area, and Industry Position
Table 81. VIC Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 82. VIC Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 83. VIC Company Profile and Main Business
Table 84. VIC Recent Developments
Table 85. Vetsintez Company Information, Head Office, Market Area, and Industry Position
Table 86. Vetsintez Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 87. Vetsintez Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 88. Vetsintez Company Profile and Main Business
Table 89. Vetsintez Recent Developments
Table 90. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 91. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 92. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 93. Cadila Pharmaceuticals Company Profile and Main Business
Table 94. Cadila Pharmaceuticals Recent Developments
Table 95. Watson International Limited Company Information, Head Office, Market Area, and Industry Position
Table 96. Watson International Limited Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 97. Watson International Limited Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 98. Watson International Limited Company Profile and Main Business
Table 99. Watson International Limited Recent Developments
Table 100. VivaldisGlenmark Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
Table 101. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Models, Specifications, and Application
Table 102. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 103. VivaldisGlenmark Pharmaceuticals Limited Company Profile and Main Business
Table 104. VivaldisGlenmark Pharmaceuticals Limited Recent Developments

List of Figures
Figure 1. Veterinary Antiparasitic Drugs Picture
Figure 2. Global Veterinary Antiparasitic Drugs Consumption Value, (US$ million) & (2021-2032)
Figure 3. Global Veterinary Antiparasitic Drugs Sales Quantity, (K Units) & (2021-2032)
Figure 4. Global Veterinary Antiparasitic Drugs Average Selling Price (ASP), (2021-2032) & (US$/Unit)
Figure 5. Japan Veterinary Antiparasitic Drugs Consumption Value, (US$ million) & (2021-2032)
Figure 6. Japan Veterinary Antiparasitic Drugs Sales Quantity (K Units) & (2021-2032)
Figure 7. Japan Veterinary Antiparasitic Drugs Average Selling Price (ASP), (US$/Unit) & (2021-2032)
Figure 8. By Consumption Value, Japan Veterinary Antiparasitic Drugs Market Share of Global, 2021-2032
Figure 9. By Sales Quantity, Japan Veterinary Antiparasitic Drugs Market Share of Global, 2021-2032
Figure 10. Global Veterinary Antiparasitic Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
Figure 11. Japan Veterinary Antiparasitic Drugs Key Participants, Market Share, 2025
Figure 12. Global Veterinary Antiparasitic Drugs Capacity, Production and Capacity Utilization, 2021-2032
Figure 13. Global Veterinary Antiparasitic Drugs Capacity Market Share by Region, 2025 VS 2032
Figure 14. Global Veterinary Antiparasitic Drugs Production Market Share & Forecast by Region, 2021-2032
Figure 15. Veterinary Antiparasitic Drugs Industry Chain
Figure 16. Veterinary Antiparasitic Drugs Procurement Model
Figure 17. Veterinary Antiparasitic Drugs Sales Model
Figure 18. Veterinary Antiparasitic Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Antihelmintics
Figure 20. Antiprotozoal Drugs
Figure 21. by Type, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032, US$ Million
Figure 22. by Type, Global Veterinary Antiparasitic Drugs Consumption Value Market Share, 2021-2032
Figure 23. by Type, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 24. by Type, Global Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2021-2032
Figure 25. by Type, Global Veterinary Antiparasitic Drugs Average Selling Price (ASP), 2021-2032, (US$/Unit)
Figure 26. Farm
Figure 27. Zoo
Figure 28. Others
Figure 29. by Application, Global Veterinary Antiparasitic Drugs Consumption Value, 2021-2032, US$ Million
Figure 30. by Application, Global Veterinary Antiparasitic Drugs Revenue Market Share, 2021-2032
Figure 31. by Application, Global Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 32. by Application, Global Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2021-2032
Figure 33. by Application, Global Veterinary Antiparasitic Drugs Price, 2021-2032, (US$/Unit)
Figure 34. By Region, Global Veterinary Antiparasitic Drugs Consumption Value Market Share, 2021-2032
Figure 35. By Region, Global Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2021-2032
Figure 36. North America Veterinary Antiparasitic Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 37. By Country, North America Veterinary Antiparasitic Drugs Consumption Value Market Share, 2025
Figure 38. Europe Veterinary Antiparasitic Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 39. By Country, Europe Veterinary Antiparasitic Drugs Consumption Value Market Share, 2025
Figure 40. Asia Pacific Veterinary Antiparasitic Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 41. By Country/Region, Asia Pacific Veterinary Antiparasitic Drugs Consumption Value Market Share, 2025
Figure 42. South America Veterinary Antiparasitic Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 43. By Country, South America Veterinary Antiparasitic Drugs Consumption Value Market Share, 2025
Figure 44. Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 45. United States Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 46. by Type, United States Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 47. by Application, United States Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 48. Europe Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 49. by Type, Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 50. by Application, Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 51. China Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 52. by Type, China Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 53. by Application, China Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 54. Japan Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 55. by Type, Japan Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 56. by Application, Japan Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 57. South Korea Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 58. by Type, South Korea Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 59. by Application, South Korea Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 60. Southeast Asia Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 61. by Type, Southeast Asia Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 62. by Application, Southeast Asia Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 63. India Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 64. by Type, India Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 65. by Application, India Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 66. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity, 2021-2032, (K Units)
Figure 67. by Type, Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 68. by Application, Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up Approaches
Figure 72. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット

購入方法

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）